Rubella

Last reviewed: 24 Apr 2022
Last updated: 30 Mar 2022

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • maculopapular rash
  • fever
  • arthralgias
  • lymphadenopathy
  • incomplete immunisation
More key diagnostic factors

Other diagnostic factors

  • malaise
  • coryza or pharyngitis
  • arthritis
  • conjunctivitis
Other diagnostic factors

Risk factors

  • incomplete immunisation
  • exposure to infectious contact
  • international travel
More risk factors

Diagnostic investigations

1st investigations to order

  • serology
  • FBC
More 1st investigations to order

Investigations to consider

  • viral culture
  • reverse-transcriptase PCR
More investigations to consider

Treatment algorithm

ACUTE

pregnant: susceptible to and exposed to rubella

non-pregnant: symptomatic rubella

Contributors

Authors

Elisabeth Adderson, MD
Elisabeth Adderson

Associate Member

St. Jude Children's Research Hospital

Associate Professor of Pediatrics

University of Tennessee Health Sciences Center

Memphis

TN

Disclosures

EA declares that she has no competing interests.

Peer reviewers

Elizabeth Barnett, MD, FAAP

Director of International Clinical Maxwell Finland Laboratory for Infectious Diseases

Boston Medical Center

Associate Professor of Pediatrics

Boston University School of Medicine

Boston

MA

Disclosures

EB has received research grant support from Sandipasteen and Intercell and received an honorarium to attend a meeting sponsored by Novartis. She receives royalties from the sale of a book she edited.

Suzanne M. Garland, MBBS, MD, FRCPAm FAChSHM, FRANZCOG ad eundem

Director of Microbiological Research

Head of Clinical Microbiology and Infectious Diseases

Royal Women's Hospital

Senior Consultant of Microbiology

Royal Children's Hospital

Professor

Faculty of Medicine, Dentistry and Health

Department of Obstetrics and Gynaecology

University of Melbourne

Melbourne

Australia

Disclosures

SMG has received advisory board fees and grant support from Commonwealth Serum Laboratories and GlaxoSmithKline, and lecture fees from Merck and GSK. SMG has received funding through her institution to conduct HPV vaccine studies for MSD and GSK.

Robert S. Duszak, OD, FAAO

Co-Director of Residency Program and Consulting Staff

Philadelphia Veterans Affairs Medical Center

Consulting Staff

Nemours Health Clinic & Mayfair Eye Associates

Adjunct Clinical Faculty

Pennsylvania College of Optometry

Salus University

Philadelphia

PA

Disclosures

RSD declares that he has no competing interests.

  • Rubella images
  • Differentials

    • Measles (rubeola)
    • Roseola infantum (HHV-6, HHV-7, exanthem subitum, sixth disease)
    • Scarlet fever (group A Streptococcus pyogenes)
    More Differentials
  • Guidelines

    • Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2022
    • Recommended adult immunization schedule for ages 19 years or older, United States, 2022
    More Guidelines
  • Patient leaflets

    Measles, mumps, and rubella: should my child have the MMR vaccine?

    More Patient leaflets
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer